Alpine Immune Sciences Inc

+0.38 (+2.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)865.35M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.14 Million
Adjusted EPS-$0.31
See more estimates
10-Day MA$13.84
50-Day MA$11.72
200-Day MA$10.42
See more pivots

Alpine Immune Sciences Inc Stock, NASDAQ:ALPN

188 East Blaine Street, Suite 200, Seattle, Washington 98102
United States of America
Phone: +1.206.788.4545
Number of Employees: 126


Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.